-
Novel STAT3 Inhibitor TT1-101 Is Safe and Shows Antitumor Activity in R/R HCC and Other Solid Tumors
09 May 2025 19:27 GMT
… pharmacokinetic profile of the agent. Pharmacodynamics before and during treatment, and …
-
Capivasertib, Fulvestrant Show Promise in Advanced Breast Cancer
09 May 2025 16:04 GMT
… response. In the context of pharmacodynamics, capivasertib functions by selectively inhibiting …
-
Pharma Fridays – May 9, 2025
09 May 2025 14:43 GMT
… exciting new space of the pharmacodynamics of natural food ligands and …
-
Protalix Biotherapeutics Reports First Quarter 2025 Financial And Business Results
09 May 2025 12:07 GMT
… safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD; reduction of uric acid …
-
Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update
09 May 2025 11:00 GMT
… the safety, tolerability, pharmacokinetics and pharmacodynamics of single- and multiple-ascending …
-
FDA Grants Fast Track Designation to IBS 2001, An Investigational Trispecific Antibody for Multiple Myeloma
08 May 2025 21:14 GMT
… , tolerability, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of ISB 2001.3 …
-
SCG101 Shows Antiviral and Antitumor Activity in Advanced HBV-Related HCC
08 May 2025 20:59 GMT
… , progression-free survival, and OS; pharmacodynamics; and the persistence of viral …
-
Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update
08 May 2025 20:01 GMT
… assess the safety, pharmacokinetics, and pharmacodynamics of single ascending doses (Part …
-
Cemsidomide Combo May Produce Responses in Multiple Myeloma
08 May 2025 18:11 GMT
… the efficacy, safety, pharmacokinetics, and pharmacodynamics of cemsidomide among patients with … Group response criteria, pharmacokinetics, and pharmacodynamics.
“With cemsidomide demonstrating compelling [ORRs …
-
Pharmacokinetics and Safety of HRS-1780 in Renal Impaired Subjects: A Multicenter, Non-Randomized, Open-Label Study
08 May 2025 12:51 GMT
… to assess safety, tolerability, pharmacokinetics, pharmacodynamics, and concentration-QTc relationship of …